Saroja Pharma Industries India Limited
The current stock price of Saroja Pharma Industries India Limited is ₹48.00, with a target price range between ₹45.60 and ₹50.40. The stock has experienced a price change of ₹0.00 (0.00%), reflecting recent market volatility.
Today's opening price was ₹0.00, while the previous close stood at ₹48.00.
The market trend suggests an uptrend, making it an attractive investment opportunity for traders seeking short-term gains.
For real-time stock market updates, live share prices, and stock analysis, stay tuned. Understanding key stock metrics like VWAP, high-low range, and market momentum can help traders make informed investment decisions.
Saroja Pharma Industries India Limited Price Chart
Saroja Pharma Industries India Limited Pre Open Market Overview: 13-Mar-2025
Key Metrics:
- IEP (Indicative Equilibrium Price): 0
- Previous Close Price: 48
- Change: -48.00%
- Total Traded Volume: 0
- Total Buy Quantity: 3,200
- Total Sell Quantity: 1,600
| Price | Buy Qty | Sell Qty |
|---|---|---|
| 0.00 | 0.00 | 0.00 |
| 39.00 | 1,600.00 | 0.00 |
| 39.10 | 1,600.00 | 0.00 |
| 54.15 | 0.00 | 1,600.00 |
ATO Data:
- Buy Quantity (ATO): 0
- Sell Quantity (ATO): 0
Order Book
| Bid | Qty | Ask | Qty |
|---|---|---|---|
| 40.20 | 1,600 | 48.00 | 1,600 |
| 40.15 | 1,600 | 54.15 | 1,600 |
| 39.10 | 1,600 | 55.50 | 1,600 |
| 38.85 | 1,600 | 56.00 | 3,200 |
| 38.55 | 1,600 | 0.00 | 0 |
Shareholding Patterns of Saroja Pharma Industries India Limited
Key Trade Statistics of Saroja Pharma Industries India Limited
| Trade Information | Details |
|---|---|
| Traded Volume (Lakhs) | N/A |
| Traded Value (₹ Cr.) | N/A |
| Total Market Cap (₹ Cr.) | 19.30 |
| Free Float Market Cap (₹ Cr.) | 5.21 |
| Impact cost | N/A |
| Quantity Traded | 4,800.00 |
| Deliverable Quantity | 3,200.00 |
| % of Quantity to Traded | 66.67 |
| Security VaR | N/A |
| Index VaR | N/A |
| VaR Margin | 50 |
| Extreme Loss Rate | 3.5 |
| Adhoc Margin | N/A |
| Applicable Margin Rate | 53.5 |
| Face Value | 10 |
Key Price Statistics of Saroja Pharma Industries India Limited
The 52-week high for Saroja Pharma Industries India Limited was ₹70.75, recorded on 05-Sep-2024. On the other hand, the 52-week low stands at ₹33.10, with the lowest value recorded on 07-Jun-2024.
The upper band for trading is ₹57.60, and the lower band is ₹38.40. The price band is 20%.
The stock's daily volatility stands at N/A, while the annualized volatility is N/A. The tick size for trading is ₹0.05.
| Price Information | Details |
|---|---|
| 52 Week High (05-Sep-2024) | 70.75 |
| 52 Week Low (07-Jun-2024) | 33.10 |
| Upper Band | 57.60 |
| Lower Band | 38.40 |
| Price Band (%) | 20 |
| Daily Volatility | - |
| Annualised Volatility | - |
| Tick Size | 0.05 |
Key Securities Statistics of Saroja Pharma Industries India Limited
| Securities Information | Details |
|---|---|
| Status | Listed |
| Trading Status | Active |
| Date of Listing | 13-Sep-2023 |
| Adjusted P/E | NA |
| Symbol P/E | NA |
| Index | NIFTY SME EMERGE |
| Macro-Economic Sector | Commodities |
| Sector | Chemicals |
| Industry | Chemicals & Petrochemicals |
| Basic Industry | Specialty Chemicals |
Security Status of Saroja Pharma Industries India Limited
| Title | Details |
|---|---|
| Board Status | SME |
| Trading Segment | Normal Market |
| Session No. | - |
| Class of Shares | Equity |
| SDD Compliance | - |
| Name of Compliance Officer | - |
Announcements of Saroja Pharma Industries India Limited
| Subject | Date |
|---|---|
| Resignation | 11-Feb-2025 |
| Certificate under SEBI (Depositories and Participants) Regulations, 2018 | 20-Jan-2025 |
| Statement of deviation(s) or variation(s) under Reg. 32 | 13-Nov-2024 |
| Financial Result Updates | 13-Nov-2024 |
| Board Meeting Intimation | 08-Nov-2024 |
| Board Meeting Intimation | 08-Nov-2024 |
| Certificate under SEBI (Depositories and Participants) Regulations, 2018 | 20-Oct-2024 |
| Updates | 02-Oct-2024 |
Corporate Actions of Saroja Pharma Industries India Limited
| Face Value | Purpose | Ex-Date |
|---|---|---|
| 10 | ANNUAL GENERAL MEETING | 23-Sep-2024 |
Board Meetings of Saroja Pharma Industries India Limited
Financial Results of Saroja Pharma Industries India Limited
Company Directory of Saroja Pharma Industries India Limited
| Web Address | Office | Address | City |
|---|---|---|---|
| - | Registered Address | 305, Kailash Tower, Shiv Shristi Complex, Goregaon Link Road Mulund West MUMBAI - 400080 MUMBAI |
MUMBAI |
| - | Corporate Office | Shop No. 209, 2nd Floor, Ecstacy, City Of Joy, Jata Shankar Dosa Marg, Mulund West MUMBAI - 400080 MUMBAI |
MUMBAI |
Insider Trading of Saroja Pharma Industries India Limited
| Reg. Clause | Acq./Disp. | Sec. Value | Txn Type | ||
|---|---|---|---|---|---|
| No insider trading information available | |||||
Annual Reports of Saroja Pharma Industries India Limited
Investor Complaints of Saroja Pharma Industries India Limited
Event Calendar of Saroja Pharma Industries India Limited
| Purpose | Details |
|---|---|
| Board Meeting Intimation | SAROJA PHARMA INDUSTRIES INDIA LIMITED has informed the Exchange about Board Meeting to be held on 13-Nov-2024 to inter-alia consider and approve the Unaudited Financial results of the Company for the Half Yearly ended September 2024 . |
| Board Meeting Intimation | SAROJA PHARMA INDUSTRIES INDIA LIMITED has informed the Exchange about Board Meeting to be held on 13-Nov-2024 to inter-alia consider and approve the Unaudited Financial results of the Company for the Half Yearly ended September 2024 . |
| Financial Results | To consider and approve the financial results for the period ended September 30, 2024 |
| SAROJA PHARMA INDUSTRIES INDIA LIMITED has informed the Exchange about Board Meeting to be held on 29-May-2024 to inter-alia consider and approve the Audited Financial results of the Company for the Yearly ended March 2024 . | Board Meeting Intimation |
| Financial Results | To consider and approve the financial results for the period ended March 31, 2024 |
| SAROJA PHARMA INDUSTRIES INDIA LIMITED has informed the Exchange about Board Meeting to be held on 09-Nov-2023 to inter-alia consider and approve the Unaudited Financial results of the Company for the Half Yearly ended September 2023 . | Board Meeting Intimation |
| Financial Results | To consider and approve the financial results for the period ended September 30, 2023 |
Share Transfers of Saroja Pharma Industries India Limited
Voting Results of Saroja Pharma Industries India Limited
| Date of Mtg. | Mtg. Type | Resolution |
|---|---|---|
| 30-SEP-2024 | AGM | To receive, consider and adopt the Audited Financial Statements of the Company for the financial year ended March 31, 2024 including the Audited Balance Sheet as at March 31, 2024, the Statement of Profit & Loss for the year ended on that date together with the reports of the Board of Directors and Auditor thereon. |
| 30-SEP-2024 | AGM | To appoint a Whole-time Director in place of Mr. Manish Dasharath Kamble, Whole-time Director (DIN: 08330224) who retires by rotation and being eligible, offers himself for re-appointment. |
FAQs on Saroja Pharma Industries India Limited
Disclaimer: The information provided here is for informational purposes only and should not be considered financial advice. Please do your own research and consult with a financial professional before making any investment decisions.